Nifty Pharma PB	4.8
Nifty Pharma PE	33.2
Nifty Pharma DIV	0.7
Nifty Pharma EPS	668.0

Nifty Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nifty Pharma from all sources in a single place.

Aurobindo Pharma Ltd.

11 Apr 2026, 10:49AM

1349.40

0.67%

Company Update

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Submission of newspaper publication.

pdf

Sun Pharmaceutical Industries Ltd.

10 Apr 2026

1654.90

-3.62%

Sun Pharma shares down 4 per cent on reports of overtures for US-based Organon

Business Line

On reports of making a bid for Organon, Sun Pharma told BSE: the information set out in the article is speculative in nature and there is no material event/information that requires disclosure under Regulation 30 of the Listing Regulations.

Sun Pharmaceutical I.. has an average target of 1940.86 from 7 brokers.

Sun Pharma stock falls 5% in strong market: What's worrying investors?

Business Standard | 10 Apr 2026

Lupin Ltd.

10 Apr 2026

2333.80

1.69%

Company Update

Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Lupin Launches Dapagliflozin Tablets in the United States.

pdf

Torrent Pharmaceuticals Ltd.

10 Apr 2026

4155.20

1.48%

Company Update

Torrent Pharmaceuticals Ltd - 500420 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

pdf

Sun Pharmaceutical Industries Ltd.

10 Apr 2026

1654.90

-3.62%

Corp. Note

Sun Pharmaceutical Industries Ltd - 524715 - Rumour verification - Regulation 30(11)

BSE India

Rumour Verification

pdf

Sun Pharmaceutical Industries Ltd.

10 Apr 2026

1654.90

-3.62%

Company Update

Sun Pharmaceutical Industries Ltd - 524715 - Clarification sought from Sun Pharmaceutical Industries Ltd

BSE India

The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on April 10, 2026, with reference to news appeared in https://www.moneycontrol.com dated April 10, 2026 quoting "Sun Pharma slips nearly 4% after $12 billion Organon deal enters final stage.".The reply is awaited.